基于Trop2的抗体-药物结合物:三阴性乳腺癌治疗的新兴策略和进展
Tong Li1, Tao Zhang2, Yongxia Dang1
1The First Clinical Medical College, Lanzhou University, No. 199 Donggang West Road, Lanzhou 730000, China.
Current oncology (Toronto, Ont.)
|February 26, 2026
概括
三重阴性乳腺癌 (TNBC) 具有很少治疗的攻击性. 针对Trop2的抗体-药物合物 (ADC) 通过向Trop2过度表达的瘤,有望改善TNBC患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
- 药物开发 药物开发
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗策略的侵袭性癌症亚型.
- 热囊细胞表面抗原2 (Trop2) 在TNBC中过度表达 (88%的病例) 并与预后不佳有关.
- Trop2的过度表达与瘤入侵和转移有关.
研究的目的:
- 审查Trop2-向抗体-药物合物 (ADCs) 对TNBC的临床进展.
- 为改善TNBC患者的治疗结果提供基于证据的见解.
主要方法:
- 对Trop2向的ADC进行临床研究的系统审查.
- 在TNBC和正常组织中分析Trop2表达.
- 对Trop2-ADC临床试验数据的评估.
主要成果:
- 由于TNBC中的高表达和正常组织中的低表达,Trop2是一个有前途的治疗标.
- 针对Trop2的ADC在治疗TNBC方面显示出显著的临床潜力.
- ADC的有效性与Trop2表达水平和瘤特征有关.
结论:
- 针对Trop2的ADCs代表了TNBC的一个有前途的治疗途径.
- 需要进一步的研究和临床试验来优化TNBC的ADC治疗.
- 向Trop2可能会改善这种侵袭性癌症亚型患者的临床结果.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
4.0K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
17.2K
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K